Drug maker Dr Reddy’s Laboratories' net profit increased to ₹722 crore in the September quarter, thereby crossing ₹700 crore quarterly profits for the first time. Net profit surged 26% against ₹574 crore in the corresponding period last year. The company's India sales increased by 14% to ₹546.4 crore, European sales rose 65% and North American sales grew by 32%. 